ProSciento, Inc.

ProSciento is a specialized contract research organization (CRO) focused on clinical development across the metabolic continuum. It supports pharmaceutical and biotechnology clients developing drugs and devices for conditions including diabetes, obesity, MASLD/MASH, cardiovascular disease, and chronic kidney disease. Its work spans clinical and regulatory planning, clinical trial design and execution, and specialized research-unit services, with patient, site, and scientific support for global programs.